Trial intelligence / Profile preview

GnRH Agonist vs Antagonist Protocols in PCOS IVF/ICSI

NCT04727671Phase 4Completed

Sponsor
Damascus University
Start
Dec 2019
Primary completion
Aug 2021
Modality
Peptides, Small Molecules
Countries
1
01

Overview

A Phase 4 trial of cetrorelix in polycystic ovary syndrome (PCOS), sponsored by Damascus University. Started Dec 2019; status: completed.

02

Drugs

cetrorelix
03

Conditions

polycystic ovary syndrome (PCOS)

Beyond the preview

Go deeper on NCT04727671.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT04727671.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call